期刊文献+

高危与耐药性滋养细胞肿瘤的处理策略 被引量:5

下载PDF
导出
摘要 妊娠滋养细胞肿瘤(gestational trophoblastic neoplasia,GTN)是指胚胎的滋养细胞发生恶变形成的肿瘤。化疗对这一恶性程度高、病情凶险的妇科肿瘤可以取得根治性的效果。然而,对于晚期多脏器转移的高危病例以及耐药性GTN的治疗仍很棘手,
作者 向阳
出处 《现代妇产科进展》 CSCD 北大核心 2011年第1期1-2,共2页 Progress in Obstetrics and Gynecology
  • 相关文献

参考文献9

  • 1Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease:de- scription and critical assessment[ J]. Int J Gynecol Canc- er,2001,11:73.
  • 2Ngan S, Seckl MJ. Gestational trophoblastic neoplasia ma- nagement:an update [ J ]. Curr Opion Oncol, 2007, 19: 486-491.
  • 3EL-Helw LM, Hancock BW. Treatment of metastic gesta- tional trophoblastic neoplasia [ J ]. Lancet Oncol, 2007,8 : 715-724.
  • 4Berkowitz RS, Goldstein DP. Current management of ges- tational trophoblastic diseases [ J ]. Gynecol Oncol, 2009, 112 : 654-662.
  • 5冯凤芝,向阳,曹杨,李雷,万希润,杨秀玉.手术联合化疗治疗耐药性妊娠滋养细胞肿瘤的疗效分析[J].中华妇产科杂志,2008,43(10):728-731. 被引量:18
  • 6Wang J,Short D, Sebire N J, et al. Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitax- el/etoposide (TP/TE) [ J ]. Ann Onco1,2008,19 : 1578-1583.
  • 7Cao Y, Xiang Y, Feng F, et al. Surgical resection in the management of pulmonary metastatic disease of gestation- al trophoblastic neoplasia [ J]. Int J Gynecol Cancer, 2009,19(4) :798-801.
  • 8Feng F, Xiang Y, Li L, et al. Clinical parameters predic- ting therapeutic response to surgical management in pa- tients with chemotherapy-resistant gestational trophoblast- ic neoplasia [ J ]. Gynecol Oncol, 2009,113 ( 3 ) : 312-315.
  • 9杨隽钧,向阳,万希润,石军荣,魏双梅,杨秀玉.妊娠滋养细胞肿瘤复发的相关因素分析和治疗[J].中华医学杂志,2006,86(1):52-55. 被引量:9

二级参考文献15

  • 1张颖,向阳,任彤,万希润,杨秀玉.恶性滋养细胞肿瘤肺转移患者肺叶切除术指征的探讨[J].中华妇产科杂志,2005,40(2):83-86. 被引量:13
  • 2孙崟,向阳,万希润,杨秀玉.绒毛膜癌复发的影响因素分析[J].中华妇产科杂志,2006,41(5):329-332. 被引量:7
  • 3Moodley M, Tunkyi K, Moodley J. Gestational trophoblastic syndrome an audit of 112 patients. A south African experience. Int J Gynecol Cancer, 2003, 13:234-239.
  • 4Song HZ, Yang XY, Xiang Y. Forty-five year's experience of the treatment of choriocarcinoma and invasive mole. Int J Gynecol Obstet, 1998, 60:S77-S83.
  • 5Ngan HYS. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer,200d.,14:202-205.
  • 6Kim SJ, Bae SN, Kim JH, et al. Effects of muhiagent chemotherapy and independent risk factors in the treatment of high-risk GTY: 25 years experiences of KRI-TRD. Int J Gynecol Obstet, 1998, 60 :S85-S96.
  • 7David GM, John TS. Recurrent gestational trophoblastic desease.Cancer, 1990, 66:978-982.
  • 8Surwit EA, Hammond CB. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol,1980, 55:565-570.
  • 9Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA)chemotherapy for patients with high-risk getational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients with metastatic placental site trophoblastic tumors. J Clin Oncol,2000,18:854-859.
  • 10Lurain JR, Nejad B. Secondary, chemotherapy for high-risk gestational trophoblaslic neoplasia. Gynecol Oncol, 2005,97:618- 623.

共引文献25

同被引文献36

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部